Cedars-Sinai

Medical Staff Pulse Newsletter

Changes at Molecular Pathology Laboratory

The Molecular Pathology Laboratory will discontinue the EGFR and KRAS single gene testing on solid tumors beginning Wednesday, April 1. The single gene tests are no longer utilized as these genes are included in the Comprehensive Cancer Panel by Next Generation Sequencing.

Also, the Molecular Pathology Laboratory has begun in‐house testing three assays that were previously sent out—Myeloid NGS Panel, Microsatellite Instability (MSI) and Calreticulin (CALR). There should be a reduction in turnaround time and increased pathologist interpretation.

For more information, see the PDFs below.

MP Updates—GFR, KRAS (PDF)  

MP Updates—In-House-Testing